Introduction
Ovarian tumors are common diseases of the female genital tract. Epithelial ovarian cancers account for the majority of female ovarian neoplasms. In the USA, the incidence of ovarian cancer is 14.5-18.1/100,000 in the general population [1] . There is a higher incidence in white women (19.8/100,000) but a lower incidence in black women (9.0/100,000) [2] . Epithelial ovarian cancers usually originate from single colonies. Tumors composed of a mixture of endocervical-type (Mullerian) mucinous cells, serous cells, endometrioid cells, squamous cells, and undifferentiated cells are classified as "seromucinous" tumors as they exhibit both serous and mucinous features. We report a patient who presented with an ovarian seromucinous tumor.
Case Report
A 27-year-old female, gravida 2, para 2, abortus 0, with no significant prior medical history presented with a palpable abdominal mass and abdominal distension. There was no abdominal pain, abnormal vaginal discharge, or bowel habit change. Physical and pelvic examinations revealed a palpable mass with mild tenderness in the pelvoabdominal region. The uterus and cervix were normal. Gynecologic ultrasonography and pelvoabdominal computed tomography revealed a huge multilocular cyst measuring 22 17 cm on the SUMMARY Objective: Ovarian tumors are commonly encountered in clinical practice. Epithelial ovarian cancers account for the majority of female ovarian neoplasms. Some uncommon ovarian mucinous tumors have recently been termed "seromucinous" tumors because they exhibit both serous and mucinous features. Case Report: A 27-year-old female patient presented with a 2-month history of a palpable abdominal mass. Ultrasonography and computed tomography revealed a huge multilocular, solid pelvic cyst. Following staging surgery, pathological sections showed that the tumor was composed of a mixture of endocervical-type mucinous, serous, endometrioid, squamous, and undifferentiated cells. An ovarian seromucinous tumor was diagnosed. The neoplastic cells were located mainly within the ovarian epithelium with only focal stromal invasion. Metastatic implants were found in the pelvic peritoneum. The patient received six courses of chemotherapy after surgery and has been regularly followed. 
Discussion
The term "seromucinous ovarian tumor" was proposed by Shappell et al to classify endocervical mucinous tumors that have similar morphologic and behavior patterns to serous tumors [3] . In 1963, the International Federation of Gynecology and Obstetrics (FIGO) accepted an intermediate group of ovarian carcinomas of low malignant potential. In 1973, the World Health Organization (WHO) adopted the term "borderline malignancies" to describe these tumors. Borderline tumors represent approximately 10-15% of all epithelial ovarian malignancies. There are discrepancies in the reported incidence of ovarian borderline malignancies [2, 4] . Borderline mucinous cystic tumors are characterized by obvious and extensive intestinalization of their epithelial lining. A minority of these tumors (5% in a tumor registry series) lack obvious intestinal epithelium. The cells resemble endocervical gland cells morphologically; therefore, they have been designated "endocervical-like" cells or "of Mullerian type". Microscopically, they do not contain the goblet or Paneth cells seen in intestinal epithelium. Papillary architec- ture is also found in these tumors, in contrast to intestinal-type mucinous tumors, which are usually multilocular, glandular, and cystic [3] . Seromucinous ovarian tumors are composed of either pure endocervical-type cells or a mixture of endocervicaltype mucinous, serous, endometrioid, squamous, and undifferentiated cells with abundant eosinophilic cytoplasm. They used to be termed "mixed epithelial papillary cystadenoma of borderline malignancy of Mullerian type". Because the tumors lack stromal invasion, they were initially termed "Mullerian mucinous or endocervical-type papillary cystadenoma of borderline malignancy". They are reported to be primarily limited to borderline and microinvasive tumors. Tumorrelated death has rarely been reported.
Atypical proliferative tumors, intraepithelial, microinvasive, and invasive carcinomas are classified according to their pathologic characteristics [3] . The presence of either intraepithelial carcinoma or microinvasion has no adverse effect on behavior. Shappell et al found that marked cytologic atypia, tumor necrosis, and mitotic index have no independent adverse impact on survival. All noninvasive tumors as well as those with microinvasion (< 5 mm) behave in a benign fashion. Micropapillary structure is related to tumor recurrence and death in advanced-stage diseases [3] . The same is true for serous ovarian tumors. Our patient had stage IIC disease. Micropapillary structures and microinvasion were both noted on pathology (Figure 3) . The patient has been disease-free for 2 years at the time of writing. DNA cytophotometry has revealed that aneuploidy is an indicator of the aggressiveness of tumors [5, 6] . DNA aneuploidy also indicates a high risk of recurrence [2] . Most borderline tumors are diploid and have good prognosis. Studies of other molecular markers have not uncovered a reliable predictor of tumor behavior. Studies involving the clinical course, prognostic analysis, and optimal therapy for this interesting group of tumors are needed. Accurate diagnosis and clinical staging lead to better treatment results, and reduce the use of unnecessary aggressive therapies.
